Clinical trial · Observational
AI-Based Prediction of Lymph Node Metastasis in Gastric Cancer Using Preoperative Multimodal Data
Artificial Intelligence-Based Prediction of Lymph Node Metastasis and Nodal Station Involvement in Gastric Cancer Using Preoperative Multimodal Imaging and Pathology Data
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aims to develop and validate an artificial intelligence (AI) system that can predict whether lymph node metastasis has occurred in patients with gastric cancer before surgery. Using preoperative imaging and pathology data, the AI models will not only predict if metastasis is present but also identify which specific lymph node stations or individual lymph nodes are involved. All lymph nodes will be carefully removed during surgery and examined one by one with detailed pathological methods to ensure accurate diagnosis. The goal is to improve the accuracy of lymph node assessment and assist doctors in making better treatment decisions.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Artificial Intelligence (AI) in Diagnosis | — | UNRESOLVED | — |
| Gastric Cancer Adenocarcinoma Metastatic | — | UNRESOLVED | — |
| Lymph Node Metastasis | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Artificial Intelligence-Based Predictive Model for Lymph Node Metastasis | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Diagnostic Accuracy of the AI Model in Predicting Presence of Lymph Node Metastasis in Gastric Cancer
- timeFrame
- From Preoperative Evaluation to Completion of Postoperative Pathological Analysis (Approximately 4-6 Weeks)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Age 18 years or older Histologically confirmed gastric adenocarcinoma Scheduled for curative-intent gastrectomy with lymphadenectomy Completed preoperative imaging with contrast-enhanced CT or MRI Available preoperative biopsy pathology report Able and willing to provide written informed consent Exclusion Criteria: * Evidence of distant metastasis on preoperative imaging Prior chemotherapy, radiotherapy, or major abdominal surgery Severe comorbidities contraindicating surgery Incomplete or poor-quality preoperative imaging or pathology data Pregnancy or lactation
References
Publications (0)
Data not yet available